Detalhe da pesquisa
1.
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission.
Blood
; 143(5): 417-421, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879077
2.
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression.
Br J Haematol
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603594
3.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
4.
Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis.
Haematologica
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546693
5.
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study.
Mod Pathol
; 36(3): 100016, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788093
6.
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.
Blood
; 138(18): 1733-1739, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115096
7.
DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.
Haematologica
; 108(6): 1604-1615, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453104
8.
STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
Haematologica
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981812
9.
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Am J Hematol
; 98(8): 1286-1306, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283522
10.
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Lancet Oncol
; 23(3): 406-415, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074072
11.
Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.
Mod Pathol
; 35(11): 1677-1683, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690645
12.
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Mod Pathol
; 35(4): 470-479, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775472
13.
3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant.
Ann Hematol
; 101(4): 847-854, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184217
14.
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
Am J Hematol
; 97(8): 1035-1043, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583199
15.
From the archives of MD Anderson Cancer Center: Intravascular large B-cell lymphoma with numerous circulating lymphoma cells.
Ann Diagn Pathol
; 58: 151934, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299081
16.
Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation.
Ann Diagn Pathol
; 56: 151860, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823075
17.
A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia.
Cancer
; 127(20): 3761-3771, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171128
18.
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.
Cancer
; 127(11): 1894-1900, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449377
19.
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia.
Br J Haematol
; 192(6): 1054-1063, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618432
20.
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.
Mod Pathol
; 34(1): 20-31, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694616